Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 04:10:10 28/10/26 pm AEDT			5-day change	1st Jan Change
7.180 ^AUD	-0.28%		-2.71%	-42.38%

20/10	Disc Medicine's late-stage win clears path for approval of sun-allergy pill	RE
01/10	Clinuvel Pharmaceuticals Ltd Presents New Patient Cases Demonstrating Clinical Response To SCENESSE With Adjunct Narrowband Ultraviolet B Phototherapy In Vitiligo Patients To EADV	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	363.1	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-29.96%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	79.97	47.46	9.974
Change	-	18.69%	-19.37%	-49.45%	4.37%	-74.13%	-40.65%	-78.99%
P/E	36.8x	30.3x	22x	14.5x	15.4x	10.4x	10.1x	7.05x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.19x	1.07x	0.94x
PEG	-	0.6x	1.2x	5.06x	-2.21x	3.13x	2.68x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	3.84x	3.62x	2.7x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	0.85x	0.47x	0.07x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	2.12x	1.21x	0.17x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	2.18x	1.24x	0.18x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	2.19x	1.18x	0.18x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	45.7%	84.7%	560%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.0592	0.0832
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.76%	0.82%	1.16%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.6902	0.7162	1.021
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.92%	8.26%	8.15%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.47	100.4	134.4
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.75	39.3	57.96
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.65	38.13	56.47
Net income ¹	20.88	30.6	35.64	36.17	33.92	34.94	36.32	51.72
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.1	-315.6	-353.1
Reference price ²	14.850	17.880	15.370	10.380	10.280	7.200	7.200	7.200
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	30/8/22	29/8/23	28/8/24	27/8/25	27/8/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	10.43x	0.85x	2.12x	0.76%	255M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	27.66x	6.46x	17.10x	1.98%	402.78B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%